Ganub, Jellie R.

HRN: 00-68-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CEFUROXIME 1.5GM (VIAL)
04/30/2022
04/30/2022
IVT
1.5g
LD
Pre-op Prophylaxis
Waiting Final Action 
04/30/2022
CEFUROXIME 500MG (TAB)
04/30/2022
05/07/2022
ORAL
500mg/tab
BID
Post Fractional D & C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: